← Back to Search

Behavioral Intervention

Naming Treatment for Aphasia

N/A

Waitlist Available

Led By Mackenzie Fama

Research Sponsored by George Washington University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Normal or corrected-to-normal hearing and vision

Are at least 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 weeks

Awards & highlights

Study Summary

This trial is looking to improve treatments for people with aphasia, a disorder that affects their ability to communicate. It aims to make it easier and faster for them to re-learn to say words they can already say in their heads.

Who is the study for?

This trial is for adults over 18 who learned English before age 5 and have aphasia from a stroke that happened at least 6 months ago. They need normal or corrected vision and hearing, plus reliable internet at home. It's not for those with serious psychiatric conditions (except common depression treatments) or other brain diseases like Parkinson's or dementia.Check my eligibility

What is being tested?

The study tests a naming treatment aimed to help people with aphasia improve their ability to say words out loud that they can already 'hear' in their head. The goal is to see if focusing on these words makes relearning speech easier, which could guide future therapy methods.See study design

What are the potential side effects?

Since this trial involves speech therapy exercises rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My hearing and vision are normal or corrected to normal.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Naming accuracy for sIS vs. uIS items (of 100%)

Secondary outcome measures

Overall naming accuracy (of 100%)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Naming TreatmentExperimental Treatment1 Intervention

Participants will complete three sessions of baseline probe testing (40 treatment items) occurring virtually on three consecutive days prior to treatment onset. Participants will then complete 10 sessions of therapy scheduled five days a week for two weeks, all occurring virtually. The treatment approach for this study will be a hierarchical, cueing-based treatment for naming.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

George Washington UniversityLead Sponsor

243 Previous Clinical Trials

453,764 Total Patients Enrolled

Mackenzie FamaPrincipal InvestigatorThe George Washington University

Media Library

Naming treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05980897 — N/A

Aphasia Research Study Groups: Naming Treatment

Aphasia Clinical Trial 2023: Naming treatment Highlights & Side Effects. Trial Name: NCT05980897 — N/A

Naming treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05980897 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the current phase of this experiment accommodate new participants?

"According to clinicaltrials.gov records, this trial is no longer recruiting patients - the original post date was July 5th 2023 and it was last updated on July 31st 2023. Currently there are 146 other medical studies that remain in search of suitable candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Inner Speech and Naming Treatment for Individuals With Aphasia

Mackenzie Fama 2023. "Inner Speech and Naming Treatment for Individuals With Aphasia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05980897.

All > Aphasia